APA (7th ed.) Citation

P, M., VJ, C., I, S., J, J., & WJ, C. (2025). Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western Canada. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 10(2), 192. https://doi.org/10.3138/jammi-2024-0034

Chicago Style (17th ed.) Citation

P, Muir, Cook VJ, Sekirov I, Johnston J, and Connors WJ. "Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western Canada." Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'infectiologie Canada 10, no. 2 (2025): 192. https://doi.org/10.3138/jammi-2024-0034.

MLA (9th ed.) Citation

P, Muir, et al. "Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western Canada." Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'infectiologie Canada, vol. 10, no. 2, 2025, p. 192, https://doi.org/10.3138/jammi-2024-0034.